Scientists Developing Early Alzheimer’s Disease Detection Sensor
Simon Fraser University
The team has completed the proof-of-concept stage and plan to move on to clinical trials
Neurobiology
Study Identifies Cause for Mysterious Cases of Epilepsy
University of California - San Diego
International collaboration uncovers mosaicism as a cause for pediatric seizures
Blood-Based Markers May Reveal Alzheimer Disease before Symptoms
Karolinska Institutet
New study on the inherited form of Alzheimer's indicates GFAP may be a possible biomarker
A New Way to Monitor Blood Flow in the Brain
Institute of Physical Chemistry of the Polish Academy of Sciences
The πNIRS technique could make life easier for doctors and patients worldwide
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
U.S. Food and Drug Administration
Leqembi has been approved via the accelerated approval pathway for the treatment of Alzheimer's
New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in Blood
University of Pittsburgh
Developing tools to detect signs of Alzheimer's in the blood is a critical step towards improving accessibility
Early Diagnosis of Neurodegenerative Diseases Could Rely on RNA
Italian Institute of Technology
The correlation between small RNA molecules and aging-related brain diseases has been described
Alzheimer’s Progression in Down Syndrome Appears Similar to Other Onset Forms
National Institutes of Health
NIH-funded study suggests people with Down syndrome may benefit from Alzheimer’s disease treatments
New WHO Brief Sets Out Actions Needed to Improve Lives of People with Epilepsy
World Health Organization
The brief supports an integrated approach to epilepsy care and better access to medication
Scientists Identify the Genetic Variant Causing ALS in Some Patients
Nagoya University
Researchers have employed human-induced pluripotent stem cells to examine mechanisms that relate to ALS